Xiangguo Qiu spends much of his time researching Virology, Ebola virus, Antibody, Monoclonal antibody and Immunology. His Virology research includes themes of Epitope and Glycoprotein. His research in Ebola virus is mostly concerned with Ebolavirus.
The concepts of his Antibody study are interwoven with issues in ZMapp and Bundibugyo virus. His study explores the link between Monoclonal antibody and topics such as Neutralization that cross with problems in Vero cell, Dengue virus, Viral membrane and Natural killer cell. His work in Virus tackles topics such as Outbreak which are related to areas like Chinese hamster ovary cell.
The scientist’s investigation covers issues in Virology, Ebola virus, Ebolavirus, Virus and Antibody. Xiangguo Qiu interconnects Immune system, Immunology and Monoclonal antibody in the investigation of issues within Virology. Xiangguo Qiu has researched Ebola virus in several fields, including Transmission, Viremia, Immunity and Glycoprotein.
His study in the field of Bundibugyo virus and Marburgvirus also crosses realms of Filoviridae. His research in Virus focuses on subjects like Viral vector, which are connected to DNA vaccination. His study in Antibody is interdisciplinary in nature, drawing from both ZMapp and In vitro.
Xiangguo Qiu focuses on Virology, Ebola virus, Virus, Antibody and Monoclonal antibody. His work deals with themes such as Glycoprotein, Immune system and Antigen, which intersect with Virology. His Ebola virus study is associated with Outbreak.
Xiangguo Qiu studies Neutralization which is a part of Antibody. His studies in Monoclonal antibody integrate themes in fields like Epitope and In vivo. His Ebolavirus study combines topics from a wide range of disciplines, such as Pathogenesis and Immunotherapy.
Xiangguo Qiu mainly investigates Ebola virus, Virology, Virus, Antibody and Ebolavirus. His research in Ebola virus intersects with topics in Nucleoprotein and Immunotherapy. His biological study spans a wide range of topics, including Ebola vaccine, Viral Vaccine, Immunogen and Antigen.
His Immunotherapy study often links to related topics such as Monoclonal antibody. His Vaccination and Antiviral drug study in the realm of Virology connects with subjects such as Post exposure. His research integrates issues of Immune system, Immunity, Immunogenicity, Viral vector and DNA vaccination in his study of Vaccination.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu;Gary Wong;Jonathan Audet;Alexander Bello.
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Xiangguo Qiu;Jonathan Audet;Gary Wong;Stephane Pillet.
Science Translational Medicine (2012)
Nanozyme-strip for rapid local diagnosis of Ebola.
Demin Duan;Kelong Fan;Dexi Zhang;Shuguang Tan.
Biosensors and Bioelectronics (2015)
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
Charles D. Murin;Marnie L. Fusco;Zachary A. Bornholdt;Xiangguo Qiu.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus
Qihui Wang;Huabing Yang;Huabing Yang;Xiaoqing Liu;Lianpan Dai.
Science Translational Medicine (2016)
Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
Gary Wong;Jason S. Richardson;Stéphane Pillet;Ami Patel;Ami Patel.
Science Translational Medicine (2012)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.
Bronwyn M. Gunn;Wen Han Yu;Marcus M. Karim;Jennifer M. Brannan.
Cell Host & Microbe (2018)
Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies
Xiangguo Qiu;Judie B. Alimonti;Judie B. Alimonti;P. Leno Melito;Lisa Fernando.
Clinical Immunology (2011)
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
Xiangguo Qiu;Lisa Fernando;Judie B. Alimonti;Judie B. Alimonti;P. Leno Melito.
PLOS ONE (2009)
Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
Erica Ollmann Saphire;Sharon L. Schendel;Marnie L. Fusco;Karthik Gangavarapu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: